Postrepolarization refractoriness as a potential anti-atrial fibrillation mechanism of pilsicainide, a pure sodium channel blocker with slow recovery kinetics

被引:22
作者
Kanki, H [1 ]
Mitamura, H [1 ]
Takatsuki, S [1 ]
Sueyoshi, K [1 ]
Shinagawa, K [1 ]
Sato, T [1 ]
Ogawa, S [1 ]
机构
[1] Keio Univ, Sch Med, Dept Med, Cardiopulm Div,Shinjuku Ku, Tokyo 1608582, Japan
关键词
atrial fibrillation; arrhythmia; refractory period; sodium channels;
D O I
10.1023/A:1007758217189
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The antifibrillatory effect of pilsicainide, a sodium channel blocker with slow recovery kinetics, was investigated in a canine model of atrial fibrillation. Prolonging the atrial effective refractory period is an important mechanism for pharmacological termination of atrial fibrillation. However, the effectiveness of potassium channel blockers has been questioned because of their reverse-use-dependent property In eight open-chest dogs, the duration of the atrial endocardial monophasic action potential and the atrial effective refractory period were determined using a Franz catheter. Conduction velocity was obtained from a 96-channel mapping electrode at multiple cycle lengths. Inducibility of sustained atrial fibrillation (>30 minutes) was confirmed by atrial burst pacing during bilateral vagal stimulation, and local fibrillation cycle lengths were measured. Five minutes after restarting fibrillation, pilsicainide (0.6 mg/kg + 0.04 mg/kg/min) was administered. After fibrillation was terminated, measurements were repeated. Pilsicainide successfully terminated atrial fibrillation in 7 of 8 dogs after the median time of 5.1 minutes. The conduction velocity decreased significantly. Although pilsicainide did not affect monophasic action potential duration, it caused use-dependent prolongation of the atrial effective refractory period (P < 0.05), creating postrepolarization refractoriness. Accordingly, pilsicainide prolonged the atrial fibrillation cycle length from 80.6 to 113.8 ms (P < 0.05) before termination of fibrillation. Sodium channel blockers with slow recovery kinetics can prolong the atrial effective refractory period without affecting monophasic action potential duration. Unlike potassium channel blockers, these sodium channel blockers maintain postrepolarization refractoriness, even at rapid stimulation rates, thus exerting a salutary antifibrillatory effect.
引用
收藏
页码:475 / 482
页数:8
相关论文
共 32 条
[1]  
[Anonymous], 1985, Cardiac arrhythmias
[2]   Conversion of recent-onset atrial fibrillation by a single oral dose of pilsicainide (Pilsicainide Suppression Trial on Atrial Fibrillation) [J].
Atarashi, H ;
Inoue, H ;
Hiejima, K ;
Hayakawa, H .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (06) :694-697
[3]   KINETICS OF ONSET OF RATE-DEPENDENT EFFECTS OF CLASS-I ANTI-ARRHYTHMIC DRUGS ARE IMPORTANT IN DETERMINING THEIR EFFECTS ON REFRACTORINESS IN GUINEA-PIG VENTRICLE, AND PROVIDE A THEORETICAL BASIS FOR THEIR SUBCLASSIFICATION [J].
CAMPBELL, TJ .
CARDIOVASCULAR RESEARCH, 1983, 17 (06) :344-352
[4]   FREQUENCY-DEPENDENT EFFECT OF QUINIDINE, MEXILETINE, AND THEIR COMBINATION ON POSTREPOLARIZATION REFRACTORINESS INVIVO [J].
COSTARDJAECKLE, A ;
LIEM, LB ;
FRANZ, MR .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 (06) :810-817
[5]   Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter [J].
Falk, RH ;
Pollak, A ;
Singh, SN ;
Friedrich, T .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) :385-390
[6]   FREQUENCY-DEPENDENT EFFECTS OF QUINIDINE ON THE RELATIONSHIP BETWEEN ACTION-POTENTIAL DURATION AND REFRACTORINESS IN THE CANINE HEART INSITU [J].
FRANZ, MR ;
COSTARD, A .
CIRCULATION, 1988, 77 (05) :1177-1184
[7]   Intravenous propafenone in paroxysmal atrial fibrillation: A randomized, placebo-controlled, double-blind, multicenter clinical trial [J].
Fresco, C ;
Proclemer, A ;
Pavan, A ;
Bula, G ;
Vicentini, A ;
Pavan, D ;
Morgera, T .
CLINICAL CARDIOLOGY, 1996, 19 (05) :409-412
[8]   ELECTROPHYSIOLOGICAL ACTIONS OF N-(2,6-DIMETHYLPHENYL)-8-PYRROLIZIDINE-ACETAMIDE HYDROCHLORIDE HEMIHYDRATE (SUN 1165), A NEW ANTIARRHYTHMIC AGENT [J].
HATTORI, Y ;
INOMATA, N ;
AISAKA, K ;
ISHIHARA, T .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 (05) :998-1002
[9]  
HERRAN J. A., 1988, CARDIOLOGY PHYSL PHA, P1